Henry Schein (HSIC) Competitors

Cardinal Health (NYSE:CAH) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations.

Does the media favor CAH or HSIC?

In the previous week, Cardinal Health had 6 more articles in the media than Henry Schein. MarketBeat recorded 21 mentions for Cardinal Health and 15 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.44 beat Cardinal Health's score of 1.26 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardinal Health	15 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	9 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is CAH or HSIC more profitable?

Henry Schein has a net margin of 2.51% compared to Cardinal Health's net margin of 0.56%. Henry Schein's return on equity of 12.90% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardinal Health	0.56%	-56.56%	4.13%
Henry Schein	2.51%	12.90%	5.21%

Do analysts rate CAH or HSIC?

Cardinal Health presently has a consensus price target of $124.58, indicating a potential downside of 0.40%. Henry Schein has a consensus price target of $78.89, indicating a potential upside of 7.10%. Given Henry Schein's stronger consensus rating and higher probable upside, analysts clearly believe Henry Schein is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardinal Health	1 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.54
Henry Schein	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.55

Do institutionals & insiders have more ownership in CAH or HSIC?

87.2% of Cardinal Health shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.1% of Cardinal Health shares are owned by insiders. Comparatively, 1.1% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Which has preferable valuation & earnings, CAH or HSIC?

Cardinal Health has higher revenue and earnings than Henry Schein. Cardinal Health is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardinal Health	$226.83B	0.13	$852M	$5.14	24.33
Henry Schein	$12.34B	0.74	$416M	$2.43	30.31

Which has more volatility & risk, CAH or HSIC?

Cardinal Health has a beta of 0.61, meaning that its stock price is 39% less volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500.

Does the MarketBeat Community believe in CAH or HSIC?

Cardinal Health received 540 more outperform votes than Henry Schein when rated by MarketBeat users. Likewise, 71.67% of users gave Cardinal Health an outperform vote while only 51.65% of users gave Henry Schein an outperform vote.

Company	Underperform	Outperform
Cardinal Health	Outperform Votes 916 71.67%	Underperform Votes 362 28.33%
Henry Schein	Outperform Votes 376 51.65%	Underperform Votes 352 48.35%

Summary

Henry Schein beats Cardinal Health on 12 of the 19 factors compared between the two stocks.